Home › News In-brief › Healthcare News ›

Merck to buy Avecia Biologics Unit

Thursday, 17 December 2009  at  13:50, Bloomberg

Merck & Co agreed to buy Avecia Investments Ltd’s biologics unit. The companies did not disclose the terms of the transaction.





Your comments

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options